The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Genetics of Parkinson's Disease
Open accessAbstract
Fifteen years of genetic research in Parkinson's disease (PD) have led to the identification of several monogenic forms of the disorder and of numerous genetic risk factors increasing the risk to develop PD. Monogenic forms, caused by a single mutation in a dominantly or recessively inherited gene, are well-established, albeit relatively rare types of PD. They collectively account for about 30% of the familial and 3%-5% of the sporadic cases. In this article, we will summarize the current knowledge and understanding of the molecular genetics of PD. In brief, we will review familial forms of PD, basic genetic principles of inheritance (and their exceptions in PD), followed by current methods for the identification of PD genes and risk factors, and implications for genetic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 2×
“Wild-type a-synuclein is selectively translocated into lysosomes for degradation (Cuervo et al. 2004), and inhibitors of the lysosomal enzyme b-glucocerebrosidase, mutations in which represent a wellvalidated risk factor for PD, modulate a-synuclein levels (Manning-Bog et al. 2009).”
BackgroundDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Self-citationAlpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria
Chen, Y., & Dorn, G. W. (2013) · Science · doi:10.1126/science.1231031 · Cited by 1,323
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 816
VPS35 mutations in Parkinson disease
Vilariño-Güell, C., Wider, C., Ross, O. A., Dachsel, J. C., Kachergus, J. M., Lincoln, S. J., Soto-Ortolaza, A. I., Cobb, S. A., Wilhoite, G. J., Bacon, J. A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.001 · Cited by 800
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 3×
“Lewy bodies are present and spread through the substantia nigra, locus ceruleus, hypothalamus, and cerebral cortex (Polymeropoulos et al. 1996).”
BackgroundThomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Hruska, K. S., LaMarca, M. E., Scott, C. R., & Sidransky, E. (2008) · Human Mutation · doi:10.1002/humu.20676 · Cited by 678
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Appel‐Cresswell, S., Vilarino‐Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Self-citation(2007) · YUHSpace (Yonsei University Medical Library) · doi:10.1016/s1474 · Cited by 641
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
(2004) · doi:10.1002/ana.10846 · Cited by 614
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi215 · Cited by 568
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
Sánchez‐Danés, A., Richaud‐Patin, Y., Carballo‐Carbajal, I., Jiménez‐Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200215 · Cited by 560
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B.-M. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002548 · Cited by 529
Self-citationLoss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 513
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
PINK1 mutations are associated with sporadic early‐onset parkinsonism
Valente, E. M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A. E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B., & Bentivoglio, A. R. (2004) · Annals of Neurology · doi:10.1002/ana.20256 · Cited by 505
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
LRRK2 in Parkinson's disease: protein domains and functional insights
Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P., & Gallo, K. A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.006 · Cited by 489
Mutations in NR4A2 associated with familial Parkinson disease
Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2003) · Nature Genetics · doi:10.1038/ng1066 · Cited by 487
Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486
Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.026 · Cited by 479
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
Fuchs, J., Nilsson, C., Kachergus, J., Munz, M., Larsson, E.-M., Schüle, B., Langston, J. W., Middleton, F. A., Ross, O. A., Hulihan, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000254458.17630.c5 · Cited by 397
Glucocerebrosidase mutations in subjects with parkinsonism
Lwin, A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.11.004 · Cited by 371
Parkinsonism among Gaucher disease carriers
Goker-Alpan, O., Schiffmann, R., LaMarca, M. E., Nussbaum, R. L., McInerney-Leo, A., & Sidransky, E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024455 · Cited by 366
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
Miller, D. W., Hague, S. M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M. R., & Singleton, A. B. (2004) · Neurology · doi:10.1212/01.wnl.0000127517.33208.f4 · Cited by 356
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
Genomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Krebs, C. E., Karkheiran, S., Powell, J. C., Cao, M., Makarov, V., Darvish, H., Di Paolo, G., Walker, R. H., Shahidi, G. A., Buxbaum, J. D., et al. (2013) · Human Mutation · doi:10.1002/humu.22372 · Cited by 336
Ross, O. A., Soto-Ortolaza, A. I., Heckman, M. G., Aasly, J. O., Abahuni, N., Annesi, G., Bacon, J. A., Bardien, S., Bozi, M., Brice, A., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70175-2 · Cited by 336
Self-citationInteraction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death
Junn, E., Taniguchi, H., Jeong, B. S., Zhao, X., Ichijo, H., & Mouradian, M. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409635102 · Cited by 321
Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism
Quadri, M., Fang, M., Picillo, M., Olgiati, S., Breedveld, G. J., Graafland, J., Wu, B., Xu, F., Erro, R., Amboni, M., et al. (2013) · Human Mutation · doi:10.1002/humu.22373 · Cited by 320
Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y.-I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036458 · Cited by 318
Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Nishioka, K., Hayashi, S., Farrer, M. J., Singleton, A. B., Yoshino, H., Imai, H., Kitami, T., Sato, K., Kuroda, R., Tomiyama, H., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20753 · Cited by 316
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. (2005) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 315
DNAJC13 mutations in Parkinson disease
Vilariño-Güell, C., Rajput, A., Milnerwood, A. J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L. N., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt570 · Cited by 313
The neuropathology of genetic Parkinson's disease
Poulopoulos, M., Levy, O. A., & Alcalay, R. N. (2012) · Movement Disorders · doi:10.1002/mds.24962 · Cited by 311
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Klein, C., Lohmann-Hedrich, K., Rogaeva, E., Schlossmacher, M. G., & Lang, A. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70174-6 · Cited by 309
Self-citationHow much phenotypic variation can be attributed to parkin genotype?
Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 301
Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
Chartier-Harlin, M.-C., Dachsel, J. C., Vilariño-Güell, C., Lincoln, S. J., Leprêtre, F., Hulihan, M. M., Kachergus, J., Milnerwood, A. J., Tapia, L., Song, M.-S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.08.009 · Cited by 299
Lesage, S., Anheim, M., Condroyer, C., Pollak, P., Durif, F., Dupuits, C., Viallet, F., Lohmann, E., Corvol, J.-C., Honoré, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq454 · Cited by 287
Ross, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20731 · Cited by 268
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M., Hasegawa, K., Ohta, E., Kawashima, N., Komiyama, M., Kowa, H., Tsuji, S., & Obata, F. (2005) · Annals of Neurology · doi:10.1002/ana.20484 · Cited by 264
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G.-A., Fakhrai-Rad, H., Ronaghi, M., & Elahi, E. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.005 · Cited by 258
α-Synuclein gene duplication is present in sporadic Parkinson disease
Ahn, T. B., Kim, S. Y., Kim, J. Y., Park, S. S., Lee, D. S., Min, H. J., Kim, Y. K., Kim, S. E., Kim, J. M., Kim, H. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000271080.53272.c7 · Cited by 249
Muhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802545105 · Cited by 248
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
Farrer, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.81 · Cited by 248
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
Pramstaller, P. P., Schlossmacher, M. G., Jacques, T. S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20587 · Cited by 247
Self-citationBiochemical and pathological characterization of Lrrk2
Giasson, B. I., Covy, J. P., Bonini, N. M., Hurtig, H. I., Farrer, M. J., Trojanowski, J. Q., & Van Deerlin, V. M. (2006) · Annals of Neurology · doi:10.1002/ana.20791 · Cited by 238
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
Anheim, M., Elbaz, A., Lesage, S., Durr, A., Condroyer, C., Viallet, F., Pollak, P., Bonaïti, B., Bonaïti-Pellié, C., & Brice, A. (2012) · Neurology · doi:10.1212/wnl.0b013e318245f476 · Cited by 238
Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts
Rakovic, A., Grünewald, A., Kottwitz, J., Brüggemann, N., Pramstaller, P. P., Lohmann, K., & Klein, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016746 · Cited by 235
Self-citationNURR1 in Parkinson disease—from pathogenesis to therapeutic potential
Decressac, M., Volakakis, N., Björklund, A., & Perlmann, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.209 · Cited by 230
Multiple Roles of Auxilin and Hsc70 in Clathrin‐Mediated Endocytosis
Eisenberg, E., & Greene, L. E. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00568.x · Cited by 215
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 211
Self-citationGlucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders
Mata, I. F., Samii, A., Schneer, S. H., Roberts, J. W., Griffith, A., Leis, B. C., Schellenberg, G. D., Sidransky, E., Bird, T. D., Leverenz, J. B., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.68 · Cited by 207
α-Synuclein: Normal Function and Role in Neurodegenerative Diseases
Norris, E. H., Giasson, B. I., & Lee, V. M.-Y. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)60002-0 · Cited by 202
Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
Rogaeva, E., Johnson, J., Lang, A. E., Gulick, C., Gwinn-Hardy, K., Kawarai, T., Sato, C., Morgan, A., Werner, J., Nussbaum, R., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1898 · Cited by 199
DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability
Köroğlu, Ç., Baysal, L., Cetinkaya, M., Karasoy, H., & Tolun, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.11.006 · Cited by 190
Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation
Bertoncini, C. W., Fernandez, C. O., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500288200 · Cited by 187
Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease
Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 178
Manning-Boğ, A. B., Schüle, B., & Langston, J. W. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.06.009 · Cited by 176
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
Clark, L. N., Wang, Y., Karlins, E., Saito, L., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000244345.49809.36 · Cited by 173
The genetics of Parkinson disease: implications for neurological care
Klein, C., & Schlossmacher, M. G. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0126 · Cited by 168
Self-citationParkin Disease: A Clinicopathologic Entity?
Doherty, K. M., Silveira-Moriyama, L., Parkkinen, L., Healy, D. G., Farrell, M., Mencacci, N. E., Ahmed, Z., Brett, F. M., Hardy, J., Quinn, N., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.172 · Cited by 163
Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts
Grünewald, A., Voges, L., Raković, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann, K., Orolicki, S., Ramírez, A., Schapira, A. H. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012962 · Cited by 160
Self-citationTsunemi, T., & Krainc, D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt572 · Cited by 159
Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson’s disease patients
Takahashi-Niki, K., Niki, T., Taira, T., Iguchi-Ariga, S. M. M., & Ariga, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.187 · Cited by 158
The many faces of alpha‐synuclein mutations
Kasten, M., & Klein, C. (2013) · Movement Disorders · doi:10.1002/mds.25499 · Cited by 157
Self-citationGBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
Tsuang, D. W., Leverenz, J. B., López, O. L., Hamilton, R. L., Bennett, D. A., Schneider, J. A., Buchman, A. S., Larson, E. B., Crane, P. K., Kaye, J. A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182735e9a · Cited by 156
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
Tan, E., Shen, H., Tan, L. C. S., Farrer, M. J., Yew, K., Chua, E., Jamora, R. D. G., Puvan, K., Puong, K. Y., Zhao, Y., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.103 · Cited by 155
Ibáñez, P., Lesage, S., Janin, S., Lohmann, E., Durif, F., Destée, A., Bonnet, A.-M., Brefel‐Courbon, C., Heath, S., Zélénika, D., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.555 · Cited by 155
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E., Gaig, C., TOLOSA, E. S., Goldwurm, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304044.22253.03 · Cited by 154
Self-citationAlcalay, R. N., Caccappolo, E., Mejia‐Santana, H., Tang, M. X., Rosado, L., Ross, B. M., Verbitsky, M., Kisselev, S., Louis, E. D., Comella, C. L., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.194 · Cited by 147
Macedo, M. G., Anar, B., Bronner, I. F., Cannella, M., Squitieri, F., Bonifati, V., Hoogeveen, A., Heutink, P., & Rizzu, P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg304 · Cited by 147
Marx, F. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg134 · Cited by 147
Hunt, R. J. (1917) · Brain · doi:10.1093/brain/40.1.58 · Cited by 147
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 144
α-Synuclein and Parkinson disease susceptibility
Winkler, S., Hagenah, J., Lincoln, S. J., Heckman, M. G., Haugarvoll, K., Lohmann-Hedrich, K., Kostić, V., Farrer, M. J., & Klein, C. (2007) · Neurology · doi:10.1212/01.wnl.0000275524.15125.f4 · Cited by 142
Self-citationPatients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Ikeuchi, T., Kakita, A., Shiga, A., Kasuga, K., Kaneko, H., Tan, C., Idezuka, J., Wakabayashi, K., Onodera, O., Iwatsubo, T., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.514 · Cited by 140
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 139
Increased incidence of Parkinson disease among relatives of patients with Gaucher disease
Halperin, A., Elstein, D., & Zimran, A. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2006.02.004 · Cited by 138
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
Li, Y., Tomiyama, H., Sato, K., Hatano, Y., Yoshino, H., Atsumi, M., Kitaguchi, M., Sasaki, S., Kawaguchi, S., Miyajima, H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000164009.36740.4e · Cited by 138
Hedrich, K., Hagenah, J. M., Djarmati, A., Hiller, A., Lohnau, T., Lasek, K., Grünewald, A., Hilker, R., Steinlechner, S., Boston, H., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.833 · Cited by 133
Self-citationModeling Lewy pathology propagation in Parkinson's disease
Luk, K. C., & Lee, V. M. ‐. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70022-1 · Cited by 132
Low frequency of α‐synuclein mutations in familial Parkinson's disease
Farrer, M. J., Vrièze, F. W., Crook, R., Boles, L., Pérez‐Tur, J., Hardy, J., Johnson, W. G., Steele, J. C., Maraganore, D. M., Gwinn, K. A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430320 · Cited by 132
Zabetian, C. P., Hutter, C. M., Yearout, D., Lopez, A. N., Factor, S. A., Griffith, A., Leis, B. C., Bird, T. D., Nutt, J. G., Higgins, D. S., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/508025 · Cited by 131
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Klein, C., Djarmati, A., Hedrich, K., Schäfer, N., Scaglione, C. L. M., Marchese, R., Kock, N., Schüle, B., Hiller, A., Lohnau, T., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201455 · Cited by 131
Self-citationLeucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Wider, C. W., Dickson, D. W., & Wszołek, Z. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289232 · Cited by 128
Athanassiadou, A., Voutsinas, G. E., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M., & Papapetropoulos, T. (1999) · The American Journal of Human Genetics · doi:10.1086/302486 · Cited by 126
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
Aasly, J. O., Vilariño‐Güell, C., Dächsel, J. C., Webber, P. J., West, A. B., Haugarvoll, K., Johansen, K. K., Toft, M., Nutt, J. G., Payami, H., et al. (2010) · Movement Disorders · doi:10.1002/mds.23265 · Cited by 125
Funayama, M., Li, Y., Tomiyama, H., Yoshino, H., Imamichi, Y., Yamamoto, M., Murata, M., Toda, T., Mizuno, Y., & Hattori, N. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32801254b6 · Cited by 124
Stamelou, M., Quinn, N. P., & Bhatia, K. P. (2013) · Movement Disorders · doi:10.1002/mds.25509 · Cited by 123
Ritz, B. R., Rhodes, S. L., Bordelon, Y. M., & Bronstein, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036199 · Cited by 120
Dopa-Responsive Dystonia Revisited
Tadić, V., Kasten, M., Brüggemann, N., Stiller, S., Hagenah, J. M., & Klein, C. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.574 · Cited by 120
Self-citationHasegawa, K., Stoessl, A. J., Yokoyama, T., Kowa, H., Wszołek, Z. K., & Yagishita, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.010 · Cited by 118
Heritability of Parkinson disease in Swedish twins: a longitudinal study
Wirdefeldt, K., Gatz, M., Reynolds, C. A., Prescott, C. A., & Pedersen, N. L. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.017 · Cited by 113
Impact of recent genetic findings in Parkinson??s disease
Klein, C., & Lohmann-Hedrich, K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281e6692b · Cited by 113
Self-citationPINK1 (PARK6) associated Parkinson disease in Ireland
Healy, D. G., Abou‐Sleiman, P. M., Gibson, J. M., Ross, O. A., Jain, S., Gandhi, S., Gosal, D. Y., Muqit, M. M. K., Wood, N. W., & Lynch, T. (2004) · Neurology · doi:10.1212/01.wnl.0000142089.38301.8e · Cited by 109
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries
Tomiyama, H., Li, Y., Funayama, M., Hasegawa, K., Yoshino, H., Kubo, S., Sato, K., Hattori, T., Lu, C., Inzelberg, R., et al. (2006) · Movement Disorders · doi:10.1002/mds.20886 · Cited by 109
Genetic neuropathology of Parkinson's disease.
Cookson, M., Hardy, J., & Lewis, P. A. (2008) · PubMed Central · Cited by 108
Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
Grimes, D. A., Han, F., Panisset, M., Racacho, L., Xiao, F., Zou, R., Westaff, K., & Bulman, D. E. (2006) · Movement Disorders · doi:10.1002/mds.20820 · Cited by 108
Sharma, M., Ioannidis, J. P. A., Aasly, J. O., Annesi, G., Brice, A., Bertram, L., Bozi, M., Barcikowska, M., Crosiers, D., Clarke, C. E., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101155 · Cited by 108
Next-Generation Phenotyping Using theParkinExample
Grünewald, A., Kasten, M., Ziegler, A., & Klein, C. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.488 · Cited by 108
Self-citationA Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction
Puschmann, A., Ross, O. A., Vilariño‐Güell, C., Lincoln, S., Kachergus, J. M., Cobb, S. A., Lindquist, S. G., Nielsen, J. E., Wszołek, Z. K., Farrer, M. J., et al. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.06.007 · Cited by 105
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
Choi, J. M., Woo, M. S., Ma, H., Kang, S. Y., Sung, Y. H., Yong, S. W., Chung, S. J., Kim, J., Shin, H., Lyoo, C. H., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0138-0 · Cited by 101
DJ-1 protects against dopamine toxicity
Lev, N., Ickowicz, D., Barhum, Y., Lev, S., Melamed, E., & Offen, D. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0134-4 · Cited by 96
The Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Eblan, M. J., Walker, J. M., & Sidransky, E. (2005) · New England Journal of Medicine · doi:10.1056/nejm200502173520719 · Cited by 96
Genetics of Parkinson's disease: LRRK2 on the rise
Brice, A. (2005) · Brain · doi:10.1093/brain/awh676 · Cited by 95
Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques
Simón‐Sánchez, J., Martí-Massó, J. F., Sanchez-Mut, J. V., Paisán‐Ruiz, C., Martínez-Gil, Á., Ruiz‐Martínez, J., Sáenz, A., Singleton, A., de Munaín, A. L., & Pérez‐Tur, J. (2006) · Movement Disorders · doi:10.1002/mds.21114 · Cited by 94
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Taylor, J. P., Mata, I. F., & Farrer, M. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.004 · Cited by 94
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
Albanese, A., Valente, E. M., Romito, L. M., Bellacchio, E., Elia, A. E., & Dallapiccola, B. (2005) · Neurology · doi:10.1212/01.wnl.0000163999.72864.fd · Cited by 88
Structural effects of Parkinson's disease linked DJ‐1 mutations
Malgieri, G., & Eliezer, D. (2008) · Protein Science · doi:10.1110/ps.073411608 · Cited by 87
Gorostidi, A., Ruiz‐Martínez, J., de Munaín, A. L., Alzualde, A., & Martí-Massó, J. F. (2008) · Neurogenetics · doi:10.1007/s10048-008-0162-0 · Cited by 81
Causal relation between α synuclein gene duplication and familial Parkinson’s disease
Inserm, U. (2005) · Dkgest of the World Latest Medical Information · Cited by 81
Genetic Complexity and Parkinson's Disease
Scott, W. K., Stajich, J. M., Yamaoka, L. H., Speer, M. C., Vance, J. M., Roses, A. D., & Pericak‐Vance, M. A. (1997) · Science · doi:10.1126/science.277.5324.387 · Cited by 78
Krüger, R., Sharma, M., Rieß, O., Gasser, T., Broeckhoven, C. V., Theuns, J., Aasly, J. O., Annesi, G., Bentivoglio, A. R., Brice, A., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.021 · Cited by 76
Self-citationWhole gene deletion and splicing mutations expand thePINK1 genotypic spectrum
Marongiu, R., Brancati, F., Antonini, A., Ialongo, T., Ceccarini, C., Scarciolla, O., Capalbo, A., Benti, R., Pezzoli, G., Dallapiccola, B., et al. (2006) · Human Mutation · doi:10.1002/humu.9472 · Cited by 76
Mutational screening of the mortalin gene (HSPA9) in Parkinson’s disease
de Mena, L., Coto, E., Sánchez-Ferrero, E., Ribacoba, R., Guisasola, L. M., Salvador, C., Estrada, M. B., & Álvarez, V. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0273-2 · Cited by 75
Fixing the broken system of genetic locus symbols
Marras, C., Lohmann, K., Lang, A. E., & Klein, C. (2012) · Neurology · doi:10.1212/wnl.0b013e31824d58ab · Cited by 74
Self-citationThe Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease
Ki, C., Stavrou, E., Davanos, Ν., Lee, W., Chung, E., Kim, J., & Athanassiadou, A. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00781.x · Cited by 73
Camargos, S., de Oliveira, L. D., Momeni, P., Lees, A. J., Hardy, J., Singleton, A., & Cardoso, F. (2009) · Movement Disorders · doi:10.1002/mds.22365 · Cited by 70
Muñoz, E., Oliva, R., Obach, V., Martı́, M. J., Pástor, P., Ballesta, F., & TOLOSA, E. S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00710-6 · Cited by 70
Genetics of Parkinson disease and other movement disorders
Kumar, K. R., Lohmann, K., & Klein, C. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283547627 · Cited by 70
Self-citationProgression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit
Eggers, C., Schmidt, A., Hagenah, J., Brüggemann, N., Klein, J. C., Tadić, V., Kertelge, L., Kasten, M., Binkofski, F., Siebner, H. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e0f79c · Cited by 68
Self-citationMotor symptoms in Parkinson's disease
Shahed, J. J., & Jankovic, J. J. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83013-2 · Cited by 65
Harbo, H. F., Finsterer, J., Baets, J., Broeckhoven, C. V., Donato, S. D., Fontaine, B., Jonghe, P. D., Lossos, A., Lynch, T., Mariotti, C., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02646.x · Cited by 64
Profiling of Parkin-Binding Partners Using Tandem Affinity Purification
Zanon, A., Raković, A., Blankenburg, H., Doncheva, N. T., Schwienbacher, C., Serafin, A., Alexa, A., Weichenberger, C. X., Albrecht, M., Klein, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078648 · Cited by 63
Self-citationOlfactory dysfunction in LRRK2 G2019S mutation carriers
Saunders-Pullman, R. J., Stanley, K. M., Wang, C., Luciano, M. S., Shanker, V., Hunt, A., Severt, L., Raymond, D., Ozelius, L. J., Lipton, R. B., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318227041c · Cited by 63
Heterozygosity for a Mendelian disorder as a risk factor for complex disease
Sidransky, E. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00688.x · Cited by 59
Mutations in DJ-1 are rare in familial Parkinson disease
Pankratz, N., Pauciulo, M. W., Elsaesser, V. E., Marek, D. K., Halter, C. A., Wojcieszek, J., Rudolph, A., Shults, C. W., Foroud, T., & Nichols, W. C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.003 · Cited by 58
Anderson, P. C., & Daggett, V. (2008) · Biochemistry · doi:10.1021/bi800677k · Cited by 49
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
Criscuolo, C., Volpe, G., Rosa, A. D., Varrone, A., Marongiu, R., Mancini, P., Salvatore, E., Dallapiccola, B., Filla, A., Valente, E. M., et al. (2006) · Movement Disorders · doi:10.1002/mds.20933 · Cited by 49
The curious case of phenocopies in families with genetic Parkinson's disease
Klein, C., Chuang, R., Marras, C., & Lang, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23853 · Cited by 46
Self-citationA case of late onset sporadic Parkinson's disease with an A53T mutation in -synuclein
Michell, A. W. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.046425 · Cited by 43
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?
Lesage, S., Condroyer, C., Klebe, S., Lohmann, E., Durif, F., Damier, P., Tison, F., Anheim, M., Honoré, A., Viallet, F., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.006 · Cited by 41
Study of the genetic variability in a Parkinson's Disease gene: EIF4G1
Tucci, A., Charlesworth, G., Sheerin, U., Plagnol, V., Wood, N. W., & Hardy, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.033 · Cited by 39
Leucine-Rich Repeat Kinase 2 for Beginners: Six Key QuestionsPreprint
Kett, L. R., & Dauer, W. T. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009407 · Cited by 38
Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
Ross, O. A., Spanaki, C., Griffith, A., Lin, C., Kachergus, J. M., Haugarvoll, K., Latsoudis, H., Plaitakis, A., Ferreira, J. J., Sampaio, C., et al. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.09.001 · Cited by 35
LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi‐center pooled analysis
Tan, E., Peng, R., Wu, Y., Wu, R., Chou, Y. W., Tan, L. C. S., An, X., Chen, C. M., Fook-Chong, S. M. C., & Lu, C.-S. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30923 · Cited by 34
PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION
Uchiyama, T., Ikeuchi, T., Ouchi, Y., Sakamoto, M., Kasuga, K., Shiga, A., Suzuki, M., Ito, M., Atsumi, T., Shimizu, T., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327607.28928.e6 · Cited by 34
Cazeneuve, C., Sân, C., Ibrahim, S. A., Mukhtar, M. M., Kheir, M. M., Leguern, É., Brice, A., & Salih, M. A. M. (2009) · Neurogenetics · doi:10.1007/s10048-009-0174-4 · Cited by 33
Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism
李, 元. (2008) · Cited by 33
The α-synuclein gene is not a major risk factor in familial Parkinson disease
Scott, W. K., Yamaoka, L. H., Stajich, J. M., Scott, B. L., Vance, J. M., Roses, A. D., Pericak‐Vance, M. A., Watts, R. L., NANCE, M. A., Hubble, J. P., et al. (1999) · Neurogenetics · doi:10.1007/s100480050083 · Cited by 29
Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study
Gelmetti, V., Ferraris, A., Brusa, L., Romano, F., Lombardi, F., Barzaghi, C., Stanzione, P., Garavaglia, B., Dallapiccola, B., & Valente, E. M. (2008) · Movement Disorders · doi:10.1002/mds.21960 · Cited by 28
α-Synuclein gene duplication is present in sporadic Parkinson disease
Troiano, A. R., Cazeneuve, C., Ber, I. L., Bonnet, A.-M., Lesage, S., & Brice, A. (2008) · Neurology · doi:10.1212/01.wnl.0000338435.78120.0f · Cited by 28
History of Parkinson's disease
Goldman, J. G., & Goetz, C. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83005-3 · Cited by 25
From GWAS to clinical utility in Parkinson's disease
Klein, C., & Ziegler, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60062-7 · Cited by 23
Self-citationClinical and demographic characteristics of PINK1 mutation carriers—A meta‐analysis
Kasten, M., Weichert, C., Lohmann, K., & Klein, C. (2010) · Movement Disorders · doi:10.1002/mds.23031 · Cited by 20
Self-citationMotor and non‐motor fluctuations
Fox, S. H., & Lang, A. E. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84039-5 · Cited by 16
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
Papapetropoulos, S. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79044-6 · Cited by 12
The neuropathology of parkinsonism
Perl, D. P. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83008-9 · Cited by 4
Cited by
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Metadata
- Authors
- Klein, C., & Westenberger, A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-01-01
- Volume
- 2
- Issue
- 1
- Pages
- a008888-a008888
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2143906078
- Cited by
- 1,358
- References
- 185
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.